Foresite Capital — Activity | F4

Team Portfolio Raise Read Contact

F4/Foresite Capital/Activity

Foresite Capital Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

3 investments· FEB 2026 – JUN 2026Show all

Investment

Participated as a new investor in Stepful's $55M Series C, led by Oak HC/FT, to expand its AI-powered healthcare workforce training platform.

Stepful

Stepful Foresite Capital

mobihealthnews.comJUN 2026

JUN 2026

Investment

Co-led Pinnacle Medicines' oversubscribed $89M Series B alongside LAV to advance its oral peptide therapeutics pipeline.

Pinnacle Medicines

Pinnacle Medicines Foresite Capital

prnewswire.comMAR 26, 2026

MAR 26, 2026

Investment

Co-led Slate Medicines' $130M Series A financing to advance anti-PACAP therapies for migraine prevention.

Slate Medicines

Slate Medicines Foresite Capital

businesswire.comFEB 24, 2026

FEB 24, 2026

News

Named to TIME's list of America's Top Venture Capital Firms for 2025.

TIME America's Top Venture Capital Firms 2025

Foresite Capital

time.comAUG 28, 2025

AUG 28, 2025

New Fund

Closed Fund VI, a $900M vehicle to back roughly 20 healthcare and life-science companies across all stages.

Fund VI

Foresite Capital

fiercebiotech.comJUN 12, 2024

JUN 12, 2024

Investment

Co-founded and backed the $1B launch of Xaira Therapeutics, an AI-driven drug discovery company, alongside ARCH Venture Partners.

Xaira Therapeutics

Xaira Therapeutics Foresite Capital

techcrunch.comAPR 24, 2024

APR 24, 2024